These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 21717805)

  • 1. Mitochondrial DNA mutations in patients with HRHPV-related cervical lesions.
    Goia-Ruşanu CD; Iancu IV; Botezatu A; Socolov D; Huică I; Pleşa A; Anton G
    Roum Arch Microbiol Immunol; 2011; 70(1):5-10. PubMed ID: 21717805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
    Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
    Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in mtDNA: a qualitative and quantitative study associated with cervical cancer development.
    Warowicka A; Kwasniewska A; Gozdzicka-Jozefiak A
    Gynecol Oncol; 2013 Apr; 129(1):193-8. PubMed ID: 23319113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing.
    Sherman ME; Schiffman MH; Lorincz AT; Herrero R; Hutchinson ML; Bratti C; Zahniser D; Morales J; Hildesheim A; Helgesen K; Kelly D; Alfaro M; Mena F; Balmaceda I; Mango L; Greenberg M
    Cancer; 1997 Apr; 81(2):89-97. PubMed ID: 9126136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ha-ras and p53 gene mutations scanned by PCR-SSCP in premalignant and malignant lesions of the uterine cervix associated with human papillomavirus].
    Alonio LV; Dalbert D; Picconi MA; Cervantes Vazquez G; García Carrancá A; Distefano AL; Mural J; Bartt O; Bazan G; Teyssie AR
    Medicina (B Aires); 2000; 60(6):895-901. PubMed ID: 11436698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application of liquid-based cytology and high-risk human papillomavirus DNA detection in cervical lesion screening].
    Wu D; Ding L; Wu JH; Li ZN
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep; 27(9):1421-3. PubMed ID: 17884792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal history of papillomavirus-induced dysplasia in the female lower genital tract.
    Vinokurova S; Wentzensen N; Einenkel J; Klaes R; Ziegert C; Melsheimer P; Sartor H; Horn LC; Höckel M; von Knebel Doeberitz M
    J Natl Cancer Inst; 2005 Dec; 97(24):1816-21. PubMed ID: 16368943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cervix uteri lesions and human papiloma virus infection (HPV): detection and characterization of DNA/HPV using PCR (polymerase chain reaction].
    Serra H; Pista A; Figueiredo P; Urbano A; Avilez F; De Oliveira CF
    Acta Med Port; 2000; 13(4):181-92. PubMed ID: 11155485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV genotypes in women with squamous intraepithelial lesions and normal cervixes participating in a community-based microbicide study in Pretoria, South Africa.
    Said HM; Ahmed K; Burnett R; Allan BR; Williamson AL; Hoosen AA
    J Clin Virol; 2009 Apr; 44(4):318-21. PubMed ID: 19269889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of combining testing for p16 protein and human papillomavirus (HPV) in cervical carcinoma screening.
    Ekalaksananan T; Pientong C; Sriamporn S; Kongyingyoes B; Pengsa P; Kleebkaow P; Kritpetcharat O; Parkin DM
    Gynecol Oncol; 2006 Oct; 103(1):62-6. PubMed ID: 16494930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for cervical neoplasia in Denmark.
    Kjaer SK
    APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of HPV testing in the follow-up of women treated for cervical dysplasia.
    Ribaldone R; Boldorini R; Capuano A; Arrigoni S; Di Oto A; Surico N
    Arch Gynecol Obstet; 2010 Aug; 282(2):193-7. PubMed ID: 20012636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus DNA detection in cervical specimens by hybrid capture: correlation with cytologic and histologic diagnoses of squamous intraepithelial lesions of the cervix.
    Hall S; Lörincz A; Shah F; Sherman ME; Abbas F; Paull G; Kurman RJ; Shah KV
    Gynecol Oncol; 1996 Sep; 62(3):353-9. PubMed ID: 8812532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Amerindian mtDNA haplogroup B2 enhances the risk of HPV for cervical cancer: de-regulation of mitochondrial genes may be involved.
    Guardado-Estrada M; Medina-Martínez I; Juárez-Torres E; Roman-Bassaure E; Macías L; Alfaro A; Alcántara-Vázquez A; Alonso P; Gomez G; Cruz-Talonia F; Serna L; Muñoz-Cortez S; Borges-Ibañez M; Espinosa A; Kofman S; Berumen J
    J Hum Genet; 2012 Apr; 57(4):269-76. PubMed ID: 22357541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 and human papilloma virus type 16 in cervical intraepithelial neoplasia and carcinoma.
    ter Harmsel B; van Belkum A; Quint W; Pronk A; Kuijpers J; Ramaekers F; Tandon A; Smedts F
    Int J Gynecol Pathol; 1995 Apr; 14(2):125-33. PubMed ID: 8601524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the D-loop region and increased copy number of mitochondrial DNA in human laryngeal squamous cell carcinoma.
    Guo W; Yang D; Xu H; Zhang Y; Huang J; Yang Z; Chen X; Huang Z
    Mol Biol Rep; 2013 Jan; 40(1):13-20. PubMed ID: 23114912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternations in mitochondrial genome in carcinogenesis of HPV positive cervix.
    Warowicka A; Wołuń-Cholewa M; Kwaśniewska A; Goździcka-Józefiak A
    Exp Mol Pathol; 2020 Dec; 117():104530. PubMed ID: 32931837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of mitochondrial DNA as potential biomarkers in breast cancer.
    Cai FF; Kohler C; Zhang B; Chen WJ; Barekati Z; Garritsen HS; Lenner P; Toniolo P; Zhang JJ; Zhong XY
    Anticancer Res; 2011 Dec; 31(12):4267-71. PubMed ID: 22199290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An association analysis between mitochondrial DNA content, G10398A polymorphism, HPV infection, and the prognosis of cervical cancer in the Chinese Han population.
    Feng D; Xu H; Li X; Wei Y; Jiang H; Xu H; Luo A; Zhou F
    Tumour Biol; 2016 Apr; 37(4):5599-607. PubMed ID: 26577855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.